Investing News NetworkYour trusted source for investing success

g1 therapeutics

G1 Therapeutics Announces Positive Topline Results from Randomized Phase 2 Trial of Trilaciclib

G1 Therapeutics Releases Phase 2 Data

G1 Therapeutics Announces Positive Myelopreservation Data

8 Top Gains and Losses at 2018’s ESMO Event

G1 Therapeutics Announces Initiation of Phase 1b/2 Clinical Trial of G1T38 in Combination with Tagrisso for EGFR-Mutant Non-Small Cell Lung Cancer

G1 Therapeutics Announces Pricing of Offering of Common Stock

G1 Therapeutics Announces Positive Trilaciclib Phase 2a Topline Data

G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights

G1 Therapeutics Closes IPO

G1 Releases Details of Upcoming IPO

NorthStar Gaming Announces Grant of Equity Incentive Awards to Non-Executive Directors in Lieu of Cash Compensation

JZR Gold Inc. Announces Private Placement Offering of Units to Raise Up To $1,500,000

Blue Lagoon Resources Officially Opens Dome Mountain Gold Mine in British Columbia

FPX Nickel Announces Share-Based Compensation Grant

Cygnus Metals Limited: Issue of Performance Rights

Maritime Resources

Triumph Gold

Quimbaya Gold

Asara Resources

International Lithium Corp.

Syntheia

MARKETS

COMMODITIES

CURRENCIES